Á lódáil...
miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells
Although daunorubicin (DNR) is the most widely used anthracycline to treat acute myeloid leukemia (AML), resistance to this drug remains a critical problem. The aim of this study was to investigate the relationship between AML resistance to daunorubicin and susceptibility to natural killer (NK) cell...
Na minha lista:
| Foilsithe in: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Taylor & Francis
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4635878/ https://ncbi.nlm.nih.gov/pubmed/26587335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2014.996475 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|